Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

1.610 -0.050 (-3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,855
Open 1.630
Bid (Size) 1.600 (2)
Ask (Size) 1.700 (5)
Prev. Close 1.660
Today's Range 1.575 - 1.850
52wk Range 0.8001 - 3.080
Shares Outstanding 41,084,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
+1.9%
+1.9%
1 Month
+15.8%
+15.8%
3 Month
+69.5%
+69.5%
6 Month
+6.6%
+6.6%
1 Year
-33.5%
-33.5%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Lifecore Biomedical Announces Cooperation Agreement with 22NW
From Lifecore Biomedical, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024
Via InvestorPlace
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
Via Benzinga
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Anebulo Pharmaceuticals Announces New CEO
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Anebulo Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Anebulo Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Anebulo Pharmaceuticals, Inc. - Common Stock trade on?
Anebulo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock is ANEB on the Nasdaq Stock Market
What is the current price of Anebulo Pharmaceuticals, Inc. - Common Stock?
The current price of Anebulo Pharmaceuticals, Inc. - Common Stock is 1.610
When was Anebulo Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Anebulo Pharmaceuticals, Inc. - Common Stock was at 07/14/25 04:00 PM ET
What is the market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock is 66.15M
How many shares of Anebulo Pharmaceuticals, Inc. - Common Stock are outstanding?
Anebulo Pharmaceuticals, Inc. - Common Stock has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.